These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6150896)

  • 1. Effect of beta-adrenergic blocking agents, with differing ancillary properties on oxotremorine induced tremor in mice.
    Alkondon M; Ray A; Sen P
    Indian J Exp Biol; 1984 Jul; 22(7):382-3. PubMed ID: 6150896
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nipradilol, a beta-adrenergic blocker with vasodilating activity, on oxotremorine-induced tremor in mice.
    Iwata S; Nomoto M; Fukuda T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):171-4. PubMed ID: 8962435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of peripheral catecholamines in oxotremorine tremor in the rat and its antagonism by beta adrenoceptor blocking agents.
    Weinstock M; Zavadil AP; Rosin AJ; Chiueh CC; Kopin IJ
    J Pharmacol Exp Ther; 1978 Jul; 206(1):91-6. PubMed ID: 26800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic involvement in the modulation of oxotremorine-tremor in mice by propranolol.
    Alkondon M; Ray A; Sen P
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):161-7. PubMed ID: 2865935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of some beta adrenergic blocking agents on the central and peripheral actions of tremorine and oxotremorine.
    Leslie GB; Hayman DG; Ireson JD; Smith S
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):108-11. PubMed ID: 4402325
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of AIT-082, a purine derivative, on tremor induced by arecoline or oxotremorine in mice.
    Nannan G; Runmei Y; Fusheng L; Shoulan Z; Guangqing L
    Pharmacology; 2007; 80(1):21-6. PubMed ID: 17496436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-blockers and nicardipine on oxotremorine-induced tremor in common marmosets.
    Mitsuda M; Nomoto M; Iwata S
    Jpn J Pharmacol; 1999 Oct; 81(2):244-6. PubMed ID: 10591485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of beta-adrenergic blockers on drug-induced tremors.
    Iwata S; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1993 Mar; 44(3):611-3. PubMed ID: 8095722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparaison, in the mouse, of two treatments for alcohol withdrawal syndrome. Inhibition of oxo tremorine-induced tremor, sedative and motor effects (author's transl)].
    Leinot M; Benoit J; Basiez M; Meunier A; Labrid C
    Ann Pharm Fr; 1979; 37(5-6):205-12. PubMed ID: 44442
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of elantrine, a new anti-Parkinsonism agent, on drug-induced tremor in mice.
    Ursillo RC; McCulloch JA
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):132-40. PubMed ID: 5031571
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptides related to melanostatin (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Lindeke B; Sievertsson H
    Acta Pharm Suec; 1976; 13(4):289-98. PubMed ID: 11638
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of some beta adrenergic blocking agents on tremorine induced tremor, hypothermia and cholinergic effects in rats.
    Singh KP; Bhandari DS; Mahawar MM
    Indian J Med Res; 1973 Oct; 61(10):1544-9. PubMed ID: 4149980
    [No Abstract]   [Full Text] [Related]  

  • 13. Tremorine-oxotremorine-induced tremor, hypothermia and analgesia, and physostigmine toxicity, in mice after pretreatment with beta-adrenoceptor antagonists.
    Barar FS; Madan BR
    J Pharm Pharmacol; 1976 Apr; 28(4):286-9. PubMed ID: 6716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device for quantitating tremor activity in mice: antitremor activity of atropine versus soman- and oxotremorine-induced tremors.
    Clement JG; Dyck WR
    J Pharmacol Methods; 1989 Aug; 22(1):25-36. PubMed ID: 2770314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tremorine effects of some beta-adrenoceptor blocking drugs in mice--a preliminary communication.
    Seth SD; Jagadeesh G; Srinivasan BP
    Indian J Med Res; 1978 Feb; 67():325-8. PubMed ID: 28287
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible involvement of the antiserotoninergic and antihistaminergic activity in the anticataleptogenic effect of EGYT-2509.
    István G; Gyertyán I; Gigler G; Somogyi E; Petöcz L
    Acta Physiol Hung; 1990; 75 Suppl():119-20. PubMed ID: 1973556
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of L-dopa, adrenergic -blockers and anticholinergic agents on the tremorine-tremor in mice.
    Watanabe H; Munakata H; Chen SC; Kasuya Y
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):372-80. PubMed ID: 4399149
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):131-3. PubMed ID: 7902979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation by naloxone of the anti-oxotremorine effect of L-DOPA.
    Quock RM; Lucas TS
    Eur J Pharmacol; 1983 Nov; 95(3-4):193-8. PubMed ID: 6653670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.